7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

ALX Oncology Holdings Inc
(NASDAQ:ALXO) 

ALXO stock logo

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the ...

Founded: 2015
Full Time Employees: 17
CEO: Jaume Pons  
Sector: Healthcare
Industry: Biotechnology
HealthcareOncology
Share this website to your friends
ALX Oncology Days Payable Outstanding ttm (DPO)
202109 202110 202111 202112 202201 202202 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.280.560.841.131.411.691.97Billion
ALX Oncology Days Inventory Outstanding ttm (DIO)
202109 202110 202111 202112 202201 202202 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1,553.4-1,331.49-1,109.57-887.66-665.74-443.83-221.910
ALX Oncology Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3.04-2.6-2.17-1.73-1.3-0.87-0.430
ALX Oncology Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3.09-2.65-2.21-1.77-1.32-0.88-0.440
ALX Oncology Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.753.515.267.018.7710.5212.28
ALX Oncology P/S ratio ttm
202109 202110 202111 202112 202201 202202 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.360.721.091.451.812.172.53Billion
ALX Oncology (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -4.28-3.67-3.06-2.45-1.84-1.22-0.610
ALX Oncology P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.4-0.75-0.10.551.21.862.513.16
No extra charts and metrics for this ticker.